Unclaimed brand
Explore IMFINZI or IMJUDO, an immunotherapy for adults with certain types of NSCLC, SCLC, BTC, GC/GEJC, uHCC, cis-eligible MIBC and dMMR endometrial cancer.
Liking this brand profile? Share this page
Hex Code
Color name
RGB
HSL
CMYK
#D6964A
Di Serria
214, 150, 74
33, 63, 56
0, 30, 65, 16
#6BBAEF
Jordy Blue
107, 186, 239
204, 80, 68
55, 22, 0, 6
#000000
Black
0, 0, 0
0, 0, 0
0, 0, 0, 100
IMFINZI® (durvalumab) is an immunotherapy brand that offers innovative treatment options for adult patients with various types of cancer. It is specifically designed for patients with metastatic NSCLC, unresectable Stage III NSCLC, extensive-stage SCLC, advanced or metastatic BTC, and unresectable HCC. As an immunotherapy, IMFINZI® (durvalumab) works by activating the immune system to fight against cancer cells.
It can be used as a standalone treatment or in combination with other medications, such as IMJUDO. For patients with unresectable Stage III non-small cell lung cancer, IMFINZI® (durvalumab) is prescribed after concurrent platinum-based chemotherapy and radiation therapy. It has shown efficacy in improving overall survival and progression-free survival rates.
In addition, IMFINZI® (durvalumab) has demonstrated promising results in treating patients with metastatic NSCLC, extensive-stage SCLC, advanced or metastatic BTC, and unresectable HCC. It has been shown to effectively prolong survival rates and improve treatment outcomes. Doctors and healthcare professionals can find valuable prescribing information, clinical guidelines, safety information, dosing recommendations, and medical resources on the brand's website.
IMFINZI® (durvalumab) is dedicated to providing support and resources to both healthcare professionals and patients on their cancer treatment journeys
Durvalumab cancer immunotherapy
PD-L1 checkpoint inhibitor therapy
Tremelimumab combination regimens
NSCLC consolidation immunotherapy
Small-cell lung cancer immunotherapy
How do I download the IMFINZI® (durvalumab) HCP logo?
The IMFINZI® (durvalumab) HCP logo comes in one version: a white logo. Download as transparent PNG.
What does IMFINZI® (durvalumab) HCP's branding look like?
The IMFINZI wordmark is a distinctive all-capital, custom geometric sans treatment, used as a clean standalone name rather than a pictorial emblem. Its visual system pairs deep navy and bright cyan-blue with white space and occasional red indication flags, using bold uppercase headings, structured evidence panels, and clinical or treatment-focused imagery.
What are IMFINZI® (durvalumab) HCP's brand colors?
The IMFINZI® (durvalumab) HCP color palette uses the hex codes #D6964A, #6BBAEF and #000000.
The IMFINZI® (durvalumab) HCP name, logos and brand assets are trademarks of IMFINZI® (durvalumab) HCP and its affiliates. Brandfetch isn't affiliated with or endorsed by IMFINZI® (durvalumab) HCP. Their use is subject to IMFINZI® (durvalumab) HCP's brand guidelines.
